<DOC>
	<DOCNO>NCT01243268</DOCNO>
	<brief_summary>This prospective , observational , open-label , multi-center study , provide detailed information safety efficacy Twynsta tablet Korean hypertensive patient require combination therapy . This present convenient treatment option hypertension Korean patient .</brief_summary>
	<brief_title>A Regulatory Requirement Post-Marketing Surveillance Study Monitor Safety Efficacy Twynsta ( Telmisartan + Amlodipine SPC , q.d . ) Korean Hypertensive Patients Requiring Combination Therapy</brief_title>
	<detailed_description>Study Design : PMS Observational study</detailed_description>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Inclusion criterion : No specific inclusion exclusion criterion provide due exploratory character study . Patients initiated Twynsta tablet accord recommend approved usage Korea consecutively enrol . Exclusion criterion : No specific inclusion exclusion criterion provide due exploratory character study . Patients initiated Twynsta tablet accord recommend approved usage Korea consecutively enrol .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>